✦ LIBER ✦

Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial

✍ Scribed by Stefan Z Wiktor; Madeleine Sassan-Morokro; Alison D Grant; Lucien Abouya; John M Karon; Chantal Maurice; Gaston Djomand; Alain Ackah; Kouao Domoua; Auguste Kadio; Achy Yapi; Patrice Combe; Odette Tossou; Thierry H Roels; Eve M Lackritz; Doulourou Coulibaly; Kevin M De Cock; Issa-Malick Coulibaly; Alan E Greenberg

Book ID: 117312775
Publisher: The Lancet
Year: 1999
Tongue: English
Weight: 122 KB
Volume: 353
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(99)03465-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early chemoprophylaxis with trimethoprim

Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial

✍ Xavier Anglaret; Geneviève Chêne; Alain Attia; Siaka Toure; Sylviane Lafont; Pat 📂 Article 📅 1999 🏛 The Lancet 🌐 English ⚖ 96 KB

Changes in HIV RNA viral load, CD4+ T-ce

Changes in HIV RNA viral load, CD4+ T-cell counts, and levels of immune activation markers associated with anti-tuberculosis therapy and cotrimoxazole prophylaxis among HIV-infected tuberculosis patients in Abidjan, Côte d'Ivoire

✍ Mireille Kalou; Madeleine Sassan-Morokro; Lucien Abouya; Célestin Bile; Chantal 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

## Abstract We analyzed changes in plasma human immunodeficiency virus (HIV)‐1 viral load, CD4+ T‐cell count, and markers of immune activation markers at start of treatment of tuberculosis and 12 months after among 44 HIV‐1‐infected patients with newly diagnosed, sputum‐smear positive for __Mycobac